Amedisys (AMED) Tops Q3 EPS by $0.16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amedisys (AMED) PT Lowered to $200 at Benchmark
October 29, 2021 7:21 AM EDTBenchmark analyst Bill Sutherland lowered the price target on Amedisys (NASDAQ: AMED) to $200.00 (from $235.00) while maintaining a Buy rating.... More
